Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Virtual Congress 2020

Pfizer - Clinical Evidence to Real-World Experience: Bridging the Best of Both Worlds in the Management of ER+ HER2- mBC

Q&A and closing

Date

20 Nov 2020

Session

Pfizer - Clinical Evidence to Real-World Experience: Bridging the Best of Both Worlds in the Management of ER+ HER2- mBC

Topics

Targeted Therapy

Tumour Site

Breast Cancer

Presenters

Tira Tan

Authors

A.M. Brufsky1, S. Dawood2, T.J.Y. Tan3

Author affiliations

  • 1 Magee-Womens Hospital of UPMC, 15213 - Pittsburgh/US
  • 2 Oncology Department, Dubai Hospital Pacemaker and EP Clinics, Dubai/AE
  • 3 Medical Oncology Department, NCCS - National Cancer Centre Singapore, 169610 - Singapore/SG

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Introductory note

Presenter: Tira Tan

Session: Pfizer - Clinical Evidence to Real-World Experience: Bridging the Best of Both Worlds in the Management of ER+ HER2- mBC

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.